Biotechnology - San Diego, California, United States
Parallume Inc. is a biotechnology company aimed at revolutionizing the field of molecular diagnostic testing for life-science researchers in academic, industrial, and clinical settings. We strive to provide reliable, cost-effective, and versatile multiplex assays for biomedical research, disease diagnosis and whole health monitoring. Parallume Inc. currently offers a novel multiplex technology platform that includes: 1) a patent-protected, bead-based optical encoding material ("Parallume" TM), 2) a series of bead localization substrates for ease of handling, and 3) a line of multiplex assay reader system ("MARS" TM) imaging instruments for both laboratory and portable, low-resource applications. The Parallume technology platform provides an unprecedented level of plex sizes and supports a numerous biological assay formats, including but not limited to real-time PCR, ELISA, and cell capture/isolation. Parallume Inc. is currently seeking opportunities for investment and/or partnership to allow for further development and commercialization of this technology.Please visit our website to learn more about our technology!https://www.parallumeinc.comAlso, please check out our publication, entitled "Multiplex Flow Assays", about our multiplex lateral flow assay (LFA) platform!https://www.ncbi.nlm.nih.gov/pubmed/27819063